Regulus Therapeutics Inc. buy HC Wainwright
Start price
25.06.24
/
50%
€1.86
Target price
25.06.25
€9.34
Performance (%)
-22.58%
Price
03.10.24
€1.47
Summary
This prediction is currently active. The prediction for Regulus Therapeutics Inc. disappoints with a performance of -22.58%. This prediction currently runs until 25.06.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Regulus Therapeutics Inc. | -2.128% | -2.128% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by HC_Wainwright for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its price target raised by analysts at HC Wainwright from $9.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for RGLS provided by MarketBeat
Stopped prediction by HC_Wainwright for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.26
06.05.24
06.05.24
€8.35
06.05.25
06.05.25
-36.28%
03.10.24
03.10.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.64
25.03.24
25.03.24
€8.30
25.03.25
25.03.25
-45.45%
03.10.24
03.10.24
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.50
19.09.23
19.09.23
€8.41
19.09.24
19.09.24
0.00%
20.09.24
20.09.24